Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript February 10, 2026 Edwards Lifesciences ...
| DelveInsight The juvenile idiopathic arthritis market is experiencing steady growth driven by rising disease awareness, improved diagnostic capabilities, and expanding access to advanced biologic ...
Samsung Electronics Co., Ltd., a global leader in advanced memory technology, today announced that it has begun mass production of its industry-leading HBM4 and has shipped commercial products to ...
Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...
Just after the close of regular trading, Edwards Lifesciences released fourth quarter and full year 2025 financial results. During today's call, management will discuss the results included in the ...
Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript February 4, 2026 Bio-Techne Corporation beats earnings ...
The newest, and most advanced cancer treatment in the world is now available to patients of Mary Mediatrix Medical Center in Lipa, Batangas, through a ...
RSSB will conduct Lab Assistant exam on May 9 and 10. Learn the subject-wise RSSB Lab Assistant Syllabus, Exam Pattern, ...
Advocate Condell Medical Center, 801 S. Milwaukee Ave., Libertyville, last month became one of the first facilities in the ...
Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.
DelveInsight's Invasive Fungal Infections Market Insights report includes a comprehensive understanding of current treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results